Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hartadinata Abadi Tbk. (HRTA) vs Merck Tbk. (MERK) Price & Performance

Hartadinata Abadi Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Hartadinata Abadi Tbk. vs Merck Tbk. — how do they compare? Hartadinata Abadi Tbk. trades at Rp2,170 (market cap 10.22T, 8.43M 24h volume), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Hartadinata Abadi Tbk. is far larger — about 5.8× Merck Tbk.'s market cap, and Hartadinata Abadi Tbk. is more actively traded (8.43M versus 63K). Which is the better fit depends on your goals.

HRTAMERK
Market Cap
10.22T1.76T
Volume
8.43M63K
Lot
84.33K630
Turnover
18.32B243.97M
Average Price
2,172.183,872.46
Value
18.32B243.97M
Indicative Equilibrium Price
2,1703,900
Indicative Equilibrium Volume
1.46K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HRTA
View details
MERK
View details

About Hartadinata Abadi Tbk.

PT Hartadinata Abadi Tbk (“the Company”) was established based on Notarial Deed No. 11 datedMarch 29, 2004 of Mayasari Soegiharto, S.H.

Read more on HRTA

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK